Effectiveness and safety of bedaquiline-based, modified all-oral 9–11-month treatment regimen for rifampicin-resistant tuberculosis in Vietnam

Effectiveness and safety of bedaquiline-based, modified all-oral 9–11-month treatment regimen for rifampicin-resistant tuberculosis in Vietnam

ABSTRACT: Objectives: World Health Organization recommends a 7-drug 9–11-month rifampicin-resistant tuberculosis (RR-TB) short treatment regimen (STR). To reduce the pill burden, we assessed the safety and effectiveness of a 5-drug 9–11-month modified STR (mSTR). Methods: Prospective cohort study o...

Full description

Bibliographic Details
Main Authors: Thi Mai Phuong Nguyen, Thi Hai Minh Le, Corinne Simone Collette Merle, Debora Pedrazzoli, Nhat Linh Nguyen, Tom Decroo, Binh Hoa Nguyen, Thi Thanh Thuy Hoang, Viet Nhung Nguyen
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:International Journal of Infectious Diseases
Subjects:
Drug-resistant tuberculosis
All-oral regimen
Shorter regimen
Bedaquiline
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971222005926

Internet

http://www.sciencedirect.com/science/article/pii/S1201971222005926

Similar Items